Cardax, Inc.
CDXI · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.04 | -0.11 | 0.53 |
| FCF Yield | -142.70% | -51.92% | -12.71% | -13.13% |
| EV / EBITDA | -2.29 | -2.35 | -6.31 | -6.97 |
| Quality | ||||
| ROIC | 57.33% | 101.29% | 116.98% | 142.46% |
| Gross Margin | 63.61% | 51.42% | 53.68% | 54.99% |
| Cash Conversion Ratio | 0.35 | 0.69 | 0.80 | 1.05 |
| Growth | ||||
| Revenue 3-Year CAGR | -29.08% | 5.22% | 249.94% | – |
| Free Cash Flow Growth | 49.61% | -10.73% | -54.15% | -63.30% |
| Safety | ||||
| Net Debt / EBITDA | -1.81 | -0.64 | 0.06 | 1.13 |
| Interest Coverage | -1.28 | -6.54 | -951.62 | -566.09 |
| Efficiency | ||||
| Inventory Turnover | 0.20 | 0.29 | 0.47 | 0.81 |
| Cash Conversion Cycle | -475.25 | -281.74 | -2.30 | -327.13 |